Our data underscores the importance of SCFAs for gut protection from GVHD, and outlines a precise SCFA receptor (GPR43) signaling pathway involving NLRP3 inflammasome activation in recipient non-hematopoietic cells (presumably IECs) that results in resistance to GVHD. Here, NLRP3 is linked to graft versus host disease.